Why treat type-2 diabetes as a chronic condition when Counterweight-Plus helps patients to remission? The intervention used in the DiRECT clinical trial saw 46% of intervention patients achieve remission at 1 year versus 4% who were on a standard NHS pathway. Speak to Counterweight to get this life-changing option for your patients.

Our site is intended for UK Healthcare Professionals

Are you a UK Healthcare Professional?

We’re sending you to our partner charity’s site. 

DRWF provide information and support for people with diabetes and their friends & families